157 related articles for article (PubMed ID: 29393219)
1. Ultra-Low Contrast Volume for Patients with Advanced Chronic Kidney Disease Undergoing Coronary Procedures.
Rozenbaum Z; Benchetrit S; Rozenbaum E; Neumark E; Mosseri M; Pereg D
Nephron; 2018; 138(4):296-302. PubMed ID: 29393219
[TBL] [Abstract][Full Text] [Related]
2. Ultra-Low Contrast Percutaneous Coronary Intervention to Minimize the Risk for Contrast-Induced Acute Kidney Injury in Patients With Severe Chronic Kidney Disease.
Azzalini L; Laricchia A; Regazzoli D; Mitomo S; Hachinohe D; Bellini B; Demir OM; Poletti E; Maccagni D; Colombo A
J Invasive Cardiol; 2019 Jun; 31(6):176-182. PubMed ID: 30865912
[TBL] [Abstract][Full Text] [Related]
3. Continuous intravenous infusion of nicorandil for 4 hours before and 24 hours after percutaneous coronary intervention protects against contrast-induced nephropathy in patients with poor renal function.
Nawa T; Nishigaki K; Kinomura Y; Tanaka T; Yamada Y; Kawasaki M; Minatoguchi S
Int J Cardiol; 2015 Sep; 195():228-34. PubMed ID: 26048382
[TBL] [Abstract][Full Text] [Related]
4. Combined impact of chronic kidney disease and contrast-induced nephropathy on long-term outcomes in patients with ST-segment elevation acute myocardial infarction who undergo primary percutaneous coronary intervention.
Nakahashi H; Kosuge M; Sakamaki K; Kiyokuni M; Ebina T; Hibi K; Tsukahara K; Iwahashi N; Kuji S; Oba MS; Umemura S; Kimura K
Heart Vessels; 2017 Jan; 32(1):22-29. PubMed ID: 27106917
[TBL] [Abstract][Full Text] [Related]
5. Ultra-low-contrast angiography in patients with advanced chronic kidney disease and previous coronary artery bypass surgery.
Rahim HM; Flattery E; Gkargkoulas F; Maehara A; Mintz GS; Hardy MA; Cohen DJ; Dube GK; Crew RJ; Mohan S; Radhakrishnan J; Ratner LE; Moses JW; Ben-Yehuda O; Kirtane AJ; Stone GW; Leon MB; Karmpaliotis D; Ali ZA
Coron Artery Dis; 2019 Aug; 30(5):346-351. PubMed ID: 31094895
[TBL] [Abstract][Full Text] [Related]
6. Minimizing radiographic contrast administration during coronary angiography using a novel contrast reduction system: A multicenter observational study of the DyeVert™ plus contrast reduction system.
Gurm HS; Mavromatis K; Bertolet B; Kereiakes DJ; Amin AP; Shah AP; Hanzel GS; Rao S; Thomas JL; Kumar G
Catheter Cardiovasc Interv; 2019 Jun; 93(7):1228-1235. PubMed ID: 30393942
[TBL] [Abstract][Full Text] [Related]
7. Age, glomerular filtration rate, ejection fraction, and the AGEF score predict contrast-induced nephropathy in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention.
Andò G; Morabito G; de Gregorio C; Trio O; Saporito F; Oreto G
Catheter Cardiovasc Interv; 2013 Nov; 82(6):878-85. PubMed ID: 23703775
[TBL] [Abstract][Full Text] [Related]
8. Reduction in Contrast Nephropathy From Coronary Angiography and Percutaneous Coronary Intervention With Ultra-Low Contrast Delivery Using an Automated Contrast Injector System.
Kelly SC; Li S; Stys TP; Thompson PA; Stys AT
J Invasive Cardiol; 2016 Nov; 28(11):446-450. PubMed ID: 27430665
[TBL] [Abstract][Full Text] [Related]
9. Zero contrast optical coherence tomography-guided percutaneous coronary intervention in patients with non-ST segment elevation myocardial infarction and chronic kidney disease.
Liu ZY; Yin ZH; Liang CY; He J; Wang CL; Peng X; Zhang Y; Zheng ZF; Pan HW
Catheter Cardiovasc Interv; 2021 May; 97 Suppl 2():1072-1079. PubMed ID: 33764682
[TBL] [Abstract][Full Text] [Related]
10. Recombinant Brain Natriuretic Peptide for the Prevention of Contrast-Induced Nephropathy in Patients with Chronic Kidney Disease Undergoing Nonemergent Percutaneous Coronary Intervention or Coronary Angiography: A Randomized Controlled Trial.
Liu J; Xie Y; He F; Gao Z; Hao Y; Zu X; Chang L; Li Y
Biomed Res Int; 2016; 2016():5985327. PubMed ID: 26949703
[TBL] [Abstract][Full Text] [Related]
11. The ratio of contrast volume to glomerular filtration rate predicts outcomes after percutaneous coronary intervention for ST-segment elevation acute myocardial infarction.
Mager A; Vaknin Assa H; Lev EI; Bental T; Assali A; Kornowski R
Catheter Cardiovasc Interv; 2011 Aug; 78(2):198-201. PubMed ID: 20949583
[TBL] [Abstract][Full Text] [Related]
12. Impact of high loading dose of atorvastatin in diabetic patients with renal dysfunction undergoing elective percutaneous coronary intervention: a randomized controlled trial.
Shehata M; Hamza M
Cardiovasc Ther; 2015 Apr; 33(2):35-41. PubMed ID: 25677920
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of nicorandil treatment for prevention of contrast-induced nephropathy in high-risk patients undergoing cardiac catheterization: A prospective randomized controlled trial.
Iranirad L; Hejazi SF; Sadeghi MS; Jang SA
Cardiol J; 2017; 24(5):502-507. PubMed ID: 28281738
[TBL] [Abstract][Full Text] [Related]
14. Remote Ischemic Preconditioning Reduces the Risk of Contrast-Induced Nephropathy in Patients with Moderate Renal Impairment Undergoing Percutaneous Coronary Angiography: A Meta-Analysis.
Deng J; Lu Y; Ou J; Shao X; Wang X; Xie H
Kidney Blood Press Res; 2020; 45(4):549-564. PubMed ID: 32688358
[TBL] [Abstract][Full Text] [Related]
15. Elevated homocysteine and the risk of contrast-induced nephropathy: a cohort study.
Barbieri L; Verdoia M; Schaffer A; Niccoli G; Perrone-Filardi P; Bellomo G; Marino P; Suryapranata H; Luca GD
Angiology; 2015 Apr; 66(4):333-8. PubMed ID: 24830422
[TBL] [Abstract][Full Text] [Related]
16. Percutaneous coronary intervention under the rigid restriction of contrast media dose in patients with chronic renal insufficiency.
Yamamoto E; Takano H; Takayama M
J Invasive Cardiol; 2006 Jun; 18(6):E169-72. PubMed ID: 16775894
[TBL] [Abstract][Full Text] [Related]
17. Predictors of outcomes of contrast-induced acute kidney injury after percutaneous coronary intervention in patients with chronic kidney disease.
Kim JH; Yang JH; Choi SH; Song YB; Hahn JY; Choi JH; Lee SH; Gwon HC
Am J Cardiol; 2014 Dec; 114(12):1830-5. PubMed ID: 25438909
[TBL] [Abstract][Full Text] [Related]
18. Brain natriuretic peptide for prevention of contrast-induced nephropathy after percutaneous coronary intervention or coronary angiography.
Liu JM; Xie YN; Gao ZH; Zu XG; Li YJ; Hao YM; Chang L
Can J Cardiol; 2014 Dec; 30(12):1607-12. PubMed ID: 25418218
[TBL] [Abstract][Full Text] [Related]
19. Contrast-Induced Nephropathy After Percutaneous Coronary Intervention for Chronic Total Occlusion Versus Non-Occlusive Coronary Artery Disease.
Demir OM; Lombardo F; Poletti E; Laricchia A; Beneduce A; Maccagni D; Slavich M; Giannini F; Carlino M; Margonato A; Cappelletti A; Colombo A; Azzalini L
Am J Cardiol; 2018 Dec; 122(11):1837-1842. PubMed ID: 30292337
[TBL] [Abstract][Full Text] [Related]
20. Imaging-guided percutaneous coronary intervention with ultra-low contrast angiographic control for patients at extreme risk of contrast induced nephropathy.
Pyka Ł; Hawranek M; Wilczek K; Piegza J; Szkodzinski J; Lekston A; Gąsior M
Cardiol J; 2019; 26(6):796-798. PubMed ID: 31970738
[No Abstract] [Full Text] [Related]
[Next] [New Search]
